证券代码：300962 证券简称：中金辐照 公告编号：2025-084 中金辐照股份有限公司 第四届董事会第二十二次会议决议的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整， 没有虚假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 本议案已经公司董事会薪酬与考核委员会审议通过。 表决结果：9 票同意，0 票反对，0 票弃权。 2.审议通过了《关于对外投资建设中金辐照秦皇岛综合灭菌中心项 目的议案》 经与会董事审议，一致认为：为推进公司战略规划实施，同意公司 投资建设中金辐照秦皇岛综合灭菌中心项目，项目总投资额约人民币 1.03 亿元，并授权经理层根据项目的实际情况办理本次投资具体事宜 （包括但不限于签署本项目相关协议，办理项目开工、施工及竣工手续 等）。 中金辐照股份有限公司（以下简称公司）第四届董事会第二十二次 会议通知于 2025 年 10 月 17 日以通讯、电子邮件发出，会议于 2025 年 10 月 27 日在公司总部会议室以现场结合通讯表决的方式举行。本次会 议应参加表决董事 9 名，实际参加表决董事 9 名。公司高级管理人员、 纪委书记列席会议，会议由公司董事长方中华先生主 ...

Core Viewpoint - The company, Zhongjin Irradiation, announced plans to invest approximately 103 million yuan in the construction of a comprehensive sterilization center in Qinhuangdao, aiming to provide high-quality and efficient sterilization services [2]. Investment Project Summary - The project will be developed in two phases, including a third-party medical disinfection supply center and a 10MeV/20kW high-energy electron accelerator irradiation center [2]. - The implementation entity for the project is Zhongjin Health Medical (Qinhuangdao) Co., Ltd., in which Zhongjin Irradiation holds a 70% stake [2]. Financial Impact - The project is not expected to have a significant short-term impact on the company's financial status and operating results [2].

Core Viewpoint - The company plans to invest approximately 103 million yuan in the construction of the Qinhuangdao Comprehensive Sterilization Center project, having signed an investment cooperation agreement with the Qinhuangdao Beidaihe New District Management Committee [1] Investment Details - The project will be developed in two phases, focusing on the establishment of a third-party medical disinfection supply center and a 10MeV/20kW high-energy electron accelerator irradiation center [1] - The total land area for the project is planned to be 20 acres, with a building area of approximately 17,000 square meters [1] - The construction period for the first phase is estimated to be around 12 months [1] Joint Venture Structure - The company intends to jointly invest with Qinhuangdao Beidaihe New District Jinchao Industrial Development Group Co., Ltd. and Zhonghong Zhijin Medical Technology (Hebei) Co., Ltd. to establish a joint venture as the project implementation entity [1] - The registered capital of the joint venture will be 30 million yuan, with the company holding a 70% stake [1]

Core Insights - The company reported a third-quarter revenue of 98.02 million yuan, representing a year-on-year increase of 5.70% [1] - The net profit for the third quarter was 23.99 million yuan, showing a decline of 23.13% compared to the previous year [1] - For the first three quarters, the total revenue reached 278 million yuan, which is a year-on-year growth of 2.33% [1] - The net profit for the first three quarters was 89.81 million yuan, reflecting a decrease of 6.35% year-on-year [1]

Revenue and Profit - The company's revenue for Q3 2025 was ¥98,016,703.28, representing a 5.70% increase compared to the same period last year[5] - Net profit attributable to shareholders decreased by 23.13% to ¥23,990,651.74 for Q3 2025[5] - The basic earnings per share for Q3 2025 was ¥0.0909, down 23.10% year-on-year[5] - Total operating revenue for the third quarter was CNY 277,844,839.39, an increase of 2.4% compared to CNY 271,524,383.77 in the same period last year[18] - Net profit for the period was CNY 92,189,136.30, a decrease of 7.2% from CNY 99,605,714.08 in the previous year[19] - Total comprehensive income attributable to the parent company was 89,805,497.79, down from 95,891,712.03 in the previous period, representing a decrease of approximately 6.9%[20] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,205,388,617.27, a 5.31% increase from the end of the previous year[5] - Total assets reached CNY 1,205,388,617.27, compared to CNY 1,144,613,365.91 at the beginning of the period, indicating a growth of 5.3%[16] - Total liabilities increased to CNY 162,234,772.56 from CNY 155,461,268.29, a rise of 4.9%[16] Shareholder Information - The top shareholder, China National Gold Group Corporation, holds 54.20% of the shares, totaling 143,099,938 shares[10] - The total number of ordinary shareholders at the end of the reporting period was 15,309[10] Cash Flow - Cash flow from operating activities for the year-to-date period was ¥129,843,311.93, down 13.60%[5] - Net cash flow from operating activities was 129,843,311.93, down from 150,280,852.78, indicating a decrease of approximately 13.6%[23] - Cash inflow from operating activities totaled 303,116,034.38, slightly down from 307,727,074.67, a decrease of about 1.9%[23] - Cash outflow from operating activities increased to 173,272,722.45 from 157,446,221.89, an increase of approximately 10.1%[23] - Net cash flow from investing activities was -168,547,080.75, worsening from -82,780,512.10, indicating a significant increase in cash outflow[23] - Cash flow from financing activities resulted in a net outflow of -36,710,665.32, compared to -68,829,816.13 in the previous period, showing an improvement of about 46.6%[23] - The ending cash and cash equivalents balance was 238,420,821.55, down from 351,830,110.93, a decrease of approximately 32.2%[23] Operational Metrics - Total operating costs amounted to CNY 182,817,284.08, up 14.3% from CNY 160,012,864.68 year-on-year[18] - Accounts receivable increased significantly to CNY 46,629,634.87 from CNY 25,144,212.59, reflecting an increase of 85.5%[15] - Inventory rose to CNY 1,733,196.24, up from CNY 466,978.91, marking a 270% increase[15] - The company's retained earnings grew to CNY 420,306,659.84 from CNY 369,045,439.01, an increase of 13.9%[16] - The company reported R&D expenses of CNY 22,454,361.23, up from CNY 17,976,444.96, reflecting a 25.5% increase year-on-year[19] Non-Recurring Items - Non-recurring gains and losses for Q3 2025 totaled -¥320,244.14, significantly lower than the previous year's amount[6] - The company did not report any net profit from the merged entity prior to the merger, consistent with the previous period[20]

Core Viewpoint - The stock of Zhongjin Irradiation has shown a positive trend with a year-to-date increase of 5.95%, reflecting investor confidence in the company's growth potential in the irradiation technology service sector [2]. Financial Performance - As of October 20, Zhongjin Irradiation reported a revenue of 180 million yuan for the first half of 2025, marking a year-on-year growth of 0.58%. The net profit attributable to the parent company was approximately 65.81 million yuan, representing a 1.75% increase year-on-year [2]. - The company has distributed a total of 303 million yuan in dividends since its A-share listing, with 234 million yuan distributed over the past three years [3]. Stock Market Activity - On October 23, the stock price increased by 2.03%, reaching 17.57 yuan per share, with a trading volume of approximately 37.44 million yuan and a turnover rate of 0.81%. The total market capitalization stood at 4.639 billion yuan [1]. - The net inflow of main funds was 2.5856 million yuan, with significant buying activity from large orders, indicating strong investor interest [1]. Business Overview - Zhongjin Irradiation, established on August 29, 2003, and listed on April 9, 2021, is located in Shenzhen, Guangdong Province. The company specializes in irradiation technology services, providing sterilization services for healthcare products, food (including pet food), pharmaceuticals, and packaging materials. The revenue composition includes 94.06% from irradiation technology services and 4.91% from high-temperature sterilization services [2]. - The company operates within the social services sector, specifically in professional services, and is associated with concepts such as pre-prepared meals, food safety, and central enterprise reform [2]. Shareholder Information - As of October 20, the number of shareholders for Zhongjin Irradiation was approximately 15,400, a decrease of 0.29% from the previous period. The average number of circulating shares per shareholder increased by 0.29% to 17,176 shares [2].

Core Points - The company, Zhongjin Radiation (300962), announced the resignation of its Deputy General Manager, Tang Qingsong, due to a job transfer [1] Group 1 - The board of directors received a written resignation report from Tang Qingsong [1] - The resignation is attributed to a work transfer [1]

Group 1 - Pinggao Electric reported a 6.98% increase in revenue to 8.436 billion yuan and a 14.62% increase in net profit to 982 million yuan for the first three quarters of 2025 [1] - Wanchen Group achieved a 77.37% increase in revenue to 36.562 billion yuan and a staggering 917.04% increase in net profit to 855 million yuan for the first three quarters of 2025 [2] - Xintian's revenue decreased by 10.42% to 481 million yuan, with a net profit decline of 35.19% to 91.9 million yuan for the first three quarters of 2025 [3] Group 2 - Chuangye Heima reported a revenue drop of 35.68% to 102 million yuan and a net loss of 24.93 million yuan for the first three quarters of 2025 [4] - Huaxin New Materials saw a 16.11% increase in revenue to 265 million yuan and an 18.56% increase in net profit to 40.81 million yuan for the first three quarters of 2025 [5] - Meihua Medical's revenue increased by 3.28% to 1.194 billion yuan, but net profit fell by 19.25% to 208 million yuan for the first three quarters of 2025 [6] Group 3 - Silica Technology reported a 24.30% increase in revenue to 2.651 billion yuan and a 44.63% increase in net profit to 229 million yuan for the first three quarters of 2025 [7] - Anada experienced a revenue decline of 6.03% to 1.31 billion yuan and a net loss of 46.37 million yuan for the first three quarters of 2025 [8] - StarNet Ruijie achieved a 19.20% increase in revenue to 14.168 billion yuan and a 31.06% increase in net profit to 344 million yuan for the first three quarters of 2025 [9] Group 4 - New Link Electronics reported a revenue decrease of 0.37% to 550 million yuan but a significant net profit increase of 421.43% to 535 million yuan for the first three quarters of 2025 [10] - Tianyin Electromechanical's revenue fell by 22.75% to 581 million yuan, with a net profit decline of 56.10% to 24.27 million yuan for the first three quarters of 2025 [11] - Hengtong Co. reported a revenue decrease of 39.29% to 1.05 billion yuan, but a net profit increase of 78.33% to 176 million yuan for the first three quarters of 2025 [12] Group 5 - Xigao Institute achieved a 15.05% revenue increase to 651 million yuan and a 21.28% net profit increase to 198 million yuan for the first three quarters of 2025 [13] - Good Housewife reported a revenue decrease of 0.91% to 1.059 billion yuan and a net profit decline of 24.79% to 143 million yuan for the first three quarters of 2025 [14] - China Pharmaceutical's subsidiary received approval for Vitamin B6 injection, indicating a positive development in its product pipeline [20] Group 6 - Xi Zhong Technology received approval for the issuance of convertible bonds, indicating potential for future capital raising [22] - Chengda Bio signed a strategic cooperation agreement with the Chinese Academy of Microbiology, focusing on infectious disease prevention [25] - Fuyuan Pharmaceutical received a drug registration certificate for Dydrogesterone tablets, enhancing its product offerings [26] Group 7 - Zhehai Deman received 8.1202 million yuan in land acquisition compensation, indicating a successful resolution of land-related issues [27] - Zhongjin Irradiation announced the resignation of its deputy general manager, indicating potential changes in management [29] - Hendi Pharmaceutical received a drug registration certificate for Febuxostat tablets, expanding its product portfolio [30] Group 8 - David Medical's subsidiary received a medical device registration certificate for a surgical stapler, enhancing its product offerings [32] - Liaoning Energy announced plans for a share reduction by a major shareholder, indicating potential changes in ownership structure [34] - Fengyuan Co. signed a framework agreement for the supply of lithium iron phosphate, indicating growth in its supply chain [35] Group 9 - Shengda Resources announced the resumption of construction at a mining site, indicating recovery from previous operational disruptions [37] - Shiyuan Co. reported a revenue increase of 5.45% to 18.087 billion yuan, but a net profit decline of 6.81% to 867 million yuan for the first three quarters of 2025 [39] - Feilida reported a revenue decrease of 6.81% to 4.659 billion yuan, but a net profit increase of 49.1% to 33.19 million yuan for the first three quarters of 2025 [40] Group 10 - Changyuan Donggu reported a revenue increase of 29.75% to 1.648 billion yuan and a net profit increase of 76.71% to 274 million yuan for the first three quarters of 2025 [41] - Liyuanheng reported a net profit of 47.49 million yuan for the first three quarters of 2025, indicating stable performance [42] - Fangyuan Co. reported a net loss of 121 million yuan for the first three quarters of 2025, indicating challenges in its operations [43] Group 11 - China Mobile reported a revenue increase of 0.4% to 794.7 billion yuan and a net profit increase of 4% to 115.4 billion yuan for the first three quarters of 2025 [44] - Huangshanghuang reported a revenue decrease of 5.08% to 1.379 billion yuan but a net profit increase of 28.59% to 101 million yuan for the first three quarters of 2025 [46] - Youcai Resources announced plans to invest approximately 150 million yuan in a new materials production base project [47] Group 12 - Huawei Technology announced plans to invest up to 20 million euros in two German subsidiaries [49] - China Shipbuilding projected a net profit increase of 144.42% to 170.85% for the first three quarters of 2025, indicating strong performance [51] - Aeston's subsidiary plans to transfer a 48% stake in a company for 245 million yuan, indicating strategic divestment [52] Group 13 - Jinxinno plans to raise up to 292 million yuan through a private placement, indicating potential for expansion [53] - China Power Construction reported a 5.04% increase in new contract amounts to 904.527 billion yuan for the first three quarters of 2025 [54] - Helitai reported a net profit increase of 101.45% to 17.81 million yuan for the first three quarters of 2025 [55] Group 14 - Xuefeng Technology reported a revenue decrease of 8.28% to 4.183 billion yuan and a net profit decline of 34.6% to 394 million yuan for the first three quarters of 2025 [57] - Juzhi Technology reported a revenue increase of 21.40% to 615 million yuan and a net profit increase of 33.78% to 82.47 million yuan for the first three quarters of 2025 [59] - Jinxi Axle reported a revenue decrease of 0.11% to 872 million yuan but a net profit increase of 268.03% to 22.11 million yuan for the first three quarters of 2025 [60] Group 15 - Longsheng Technology reported a revenue increase of 10.13% to 1.810 billion yuan and a net profit increase of 36.89% to 210 million yuan for the first three quarters of 2025 [62] - Shannon Chip Creation announced plans for a share reduction by a major shareholder, indicating potential changes in ownership structure [63]

Group 1 - The core point of the article is the resignation of Mr. Tang Qingsong from his position as Vice General Manager of the company due to a job transfer, and he will no longer hold any position within the company after his resignation [1] Group 2 - The article includes an interview with He Keng, emphasizing the need to change the previous tendency of over-concentrating funds in housing and infrastructure construction, and to place more emphasis on investments in the livelihood sector [1]

中金辐照10月21日公告，公司董事会于近日收到公司副总经理汤清松递交的书面辞职报告。因工作调 动，汤清松申请辞去公司副总经理职务，辞职报告自送达董事会之日起生效。辞职后，汤清松将不再担 任公司任何职务。 ...